• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[制定关于使用血管活性药物治疗慢性静脉疾病的建议——其有效之处与无效之处]

[Development of recommendations for the use of venoactive drugs in the treatment of chronic venous disease - where they are effective and where they are not].

作者信息

Musil Dalibor

出版信息

Vnitr Lek. 2022 Fall;68(4):234-239.

PMID:36220421
Abstract

The article provides an overview of the development of recommendations for indications of venoactive drugs for treating symptoms and signs associated with chronic venous disease (CVD). Venoactive drugs may be beneficial in patients with subjective problems and/or swelling of the lower limbs, after surgery for varicose veins, in chronic venous insufficiency or in microcirculatory disorders. They are not indicated in asymptomatic patients with CVD, in the prevention of varicose veins or to prevent their progression. Drugs with proven efficacy in clinical trials should be preferred.

摘要

本文概述了治疗与慢性静脉疾病(CVD)相关症状和体征的血管活性药物适应证推荐的发展情况。血管活性药物可能对有主观症状和/或下肢肿胀的患者、静脉曲张手术后患者、慢性静脉功能不全患者或微循环障碍患者有益。对于无症状的CVD患者、预防静脉曲张或预防其进展,不推荐使用血管活性药物。应优先选用在临床试验中已证实疗效的药物。

相似文献

1
[Development of recommendations for the use of venoactive drugs in the treatment of chronic venous disease - where they are effective and where they are not].[制定关于使用血管活性药物治疗慢性静脉疾病的建议——其有效之处与无效之处]
Vnitr Lek. 2022 Fall;68(4):234-239.
2
Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.微粉化纯化黄酮类化合物(达芙通®)改善慢性静脉疾病患者个体症状、体征及生活质量的疗效:一项随机双盲安慰剂对照试验的系统评价与荟萃分析
Int Angiol. 2018 Apr;37(2):143-154. doi: 10.23736/S0392-9590.18.03975-5. Epub 2018 Jan 31.
3
Changes of the serum properties and its effect on the endothelial cells restoration in patients with chronic venous disease treated with sulodexide.舒洛地特治疗慢性静脉疾病患者时血清特性的变化及其对内皮细胞修复的影响。
J Vasc Surg Venous Lymphat Disord. 2024 Sep;12(5):101941. doi: 10.1016/j.jvsv.2024.101941. Epub 2024 Jun 28.
4
Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence.微粉化纯化黄酮类混合物(MPFF)治疗慢性静脉疾病患者:新证据综述。
Adv Ther. 2019 Mar;36(Suppl 1):20-25. doi: 10.1007/s12325-019-0884-4. Epub 2019 Feb 13.
5
Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs.心血管洞察:慢性静脉疾病的合理管理:血管活性药物应用相关影响的叙述性综述。
Adv Ther. 2023 Dec;40(12):5137-5154. doi: 10.1007/s12325-023-02657-0. Epub 2023 Sep 28.
6
LivRelief varicose veins cream in the treatment of chronic venous insufficiency of the lower limbs: A 6-week single arm pilot study.LivRelief 静脉曲张乳膏治疗下肢慢性静脉功能不全:一项为期 6 周的单臂先导研究。
PLoS One. 2018 Dec 31;13(12):e0208954. doi: 10.1371/journal.pone.0208954. eCollection 2018.
7
Sulodexide for the Symptoms and Signs of Chronic Venous Disease: A Systematic Review and Meta-analysis.舒洛地特治疗慢性静脉疾病的症状和体征:系统评价和荟萃分析。
Adv Ther. 2020 Mar;37(3):1013-1033. doi: 10.1007/s12325-020-01232-1. Epub 2020 Jan 27.
8
The Seriousness of Chronic Venous Disease: A Review of Real-World Evidence.慢性静脉疾病的严重性:真实世界证据的综述。
Adv Ther. 2019 Mar;36(Suppl 1):5-12. doi: 10.1007/s12325-019-0881-7. Epub 2019 Feb 13.
9
Sulodexide: it is time for a program against chronic venous disease.舒洛地特:是时候开展一项针对慢性静脉疾病的项目了。
Int Angiol. 2014 Jun;33(3):209-11.
10
[Value of venoactive substances in phlebology. Treatment of varicose veins and post-thrombotic syndrome].
Fortschr Med. 1986 Dec 18;104(47-48):963-4.